Final Results from the
OPERA Study Released

Topical Analgesics Reduce Opioid Usage over 3 and 6-months

VIEW PEER-REVIEWED JOURNAL

“Understanding all available treatment options, tailoring therapy to the individual, while being knowledgeable of the current opioid crisis is crucial in today’s environment. Outcomes from The OPERA Study demonstrate that there are alternative approaches that allow clinicians to successfully treat a patient’s pain while addressing and mitigating risks.”

Peter Hurwitz
President, Clarity Science

See informative results from our studies.

Current Scar Study

TARGET

(TopicAl Silicone in RestorinG Scars and Burn Tissue Evaluating Therapy)

Positive interim TARGET Results have been presented at leading conferences, including the 7th Joint Meeting of the European Tissue Repair Society & the Wound Healing Society held in Copenhagen, Denmark, among others.

ETRS Wound-Healing-Society-Logo-BW

Results from an interim analysis of our TARGET study (a scar and burn treatment study) show that adults using a prescribed topical scar and burn cream reported:

Size
Reduced scar/burn size as measured by clinicians and as perceived by patients.
Itch
Reduced itching.
Mood
Reduced scar/burn interference with general activity, mood, sleep, and life enjoyment.
Pain_Meds
Reduced pain medication use.

VIEW TARGET POSTER SEE TARGET STUDY DETAILS

Closed Pain Study

OPERA

(Optimizing Patient Experience and Response to Topical Analgesics)

Positive interim OPERA Results have been presented at important conferences, including the 4th Annual International Conference on Opioids held at Harvard Medical School, among others.

Opioidsharvard medical schoolACRPharvard medical school

Results from an interim analysis of our OPERA study (a pain study) show that patients with musculoskeletal and neuropathic pain using a prescribed topical analgesic reported:

Pain_Severity
Reduced pain severity for patients with neuropathic and musculoskeletal pain.
Daily_Activity
Reduced pain interference with general activity, mood, sleep, and life enjoyment.
Arthritis
Reduced number of primary pain complaints for arthritis, neuropathy, or radiculopathy.
OTC_Meds
Reduced use of over-the-counter medications, anti-inflammatory medications, and opioid analgesics.

VIEW OPERA POSTER SEE OPERA STUDY DETAILS

Conference & Publications Highlights

MORE CONFERENCES & PUBLICATIONS

5th Annual International Conference on Opioids
June 5-7, 2016
Boston, Massachusetts, USA

Clarity presented statistically-significant interim data from our OPERA study, a pain management study.

15th Annual APWCA (American Professional Wound Care Association) 2016 National Clinical Conference: Mapping Extraordinary Care, Setting the Course for Excellence
March 31- April 2, 2016
Philadelphia, PA, USA

Clarity presented data from our TARGET Study at APWCA.

Clarity was awarded First Place for Best Scientific Presentation/Data.

AAPM’s (American Academy of Pain Medicine’s) 32nd Annual Meeting, Ensuring Access to Pain Care: Engaging Pain Medicine and Primary Care Teams
February 18-21, 2016
Palm Springs, California, USA

Clarity will present interim data from our OPERA study, a pain management study.

News & Announcements

VISIT OUR NEWS PAGE